These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20166965)
21. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Pardridge WM; Boado RJ Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573 [TBL] [Abstract][Full Text] [Related]
22. Delivery of Superoxide Dismutase Using Cys Liu J; Li J; Li J; Zhu L; Wang S; Wei X; Ma P Methods Mol Biol; 2018; 1867():113-123. PubMed ID: 30155819 [TBL] [Abstract][Full Text] [Related]
23. Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides. Basheer M; Schwalb H; Shefler I; Levdansky L; Mekori YA; Gorodetsky R Peptides; 2011 Dec; 32(12):2444-51. PubMed ID: 21971370 [TBL] [Abstract][Full Text] [Related]
24. Design of target-seeking antifibrotic compounds. Järvinen TA Methods Enzymol; 2012; 509():243-61. PubMed ID: 22568909 [TBL] [Abstract][Full Text] [Related]
25. NMR analysis of the binding of a rhodanese peptide to a minichaperone in solution. Kobayashi N; Freund SM; Chatellier J; Zahn R; Fersht AR J Mol Biol; 1999 Sep; 292(1):181-90. PubMed ID: 10493867 [TBL] [Abstract][Full Text] [Related]
26. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease. Nagel F; Falkenburger BH; Tönges L; Kowsky S; Pöppelmeyer C; Schulz JB; Bähr M; Dietz GP J Neurochem; 2008 May; 105(3):853-64. PubMed ID: 18182047 [TBL] [Abstract][Full Text] [Related]
27. Delivery of bioactive molecules into the cell: the Trojan horse approach. Dietz GP; Bähr M Mol Cell Neurosci; 2004 Oct; 27(2):85-131. PubMed ID: 15485768 [TBL] [Abstract][Full Text] [Related]
28. Chemical synthesis of cell-permeable apoptotic peptides from in vivo produced proteins. Fricke T; Mart RJ; Watkins CL; Wiltshire M; Errington RJ; Smith PJ; Jones AT; Allemann RK Bioconjug Chem; 2011 Sep; 22(9):1763-7. PubMed ID: 21823633 [TBL] [Abstract][Full Text] [Related]
29. Cell-penetrating peptides as a novel transdermal drug delivery system. Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609 [TBL] [Abstract][Full Text] [Related]
31. Smart delivery of poly-peptide composite for effective cancer therapy. Yuan X; Qin Y; Tian Q; Liu C; Meng X; Qie B; Gao F; Huang Y; Xu G; Yang G; Zhu Y Biomed Mater; 2022 Jan; 17(2):. PubMed ID: 34996052 [TBL] [Abstract][Full Text] [Related]
32. Induction of molecular chaperones by hyperosmotic stress in mouse inner medullary collecting duct cells. Rauchman MI; Pullman J; Gullans SR Am J Physiol; 1997 Jul; 273(1 Pt 2):F9-17. PubMed ID: 9249587 [TBL] [Abstract][Full Text] [Related]
33. Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin. Bae HD; Kim M; Lee J; Lee K Drug Deliv; 2018 Nov; 25(1):1579-1584. PubMed ID: 30044154 [TBL] [Abstract][Full Text] [Related]
34. The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide. Kim H; Seo EH; Lee SH; Kim BJ Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941629 [TBL] [Abstract][Full Text] [Related]
36. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Baranyi L; Campbell W; Ohshima K; Fujimoto S; Boros M; Okada H Nat Med; 1995 Sep; 1(9):894-901. PubMed ID: 7585214 [TBL] [Abstract][Full Text] [Related]
37. The kinetics and tissue distribution of protein transduction in mice. Cai SR; Xu G; Becker-Hapak M; Ma M; Dowdy SF; McLeod HL Eur J Pharm Sci; 2006 Mar; 27(4):311-9. PubMed ID: 16376528 [TBL] [Abstract][Full Text] [Related]
38. Recombinant human serum albumin fusion proteins and novel applications in drug delivery and therapy. Rogers B; Dong D; Li Z; Li Z Curr Pharm Des; 2015; 21(14):1899-907. PubMed ID: 25732550 [TBL] [Abstract][Full Text] [Related]
39. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting. Ye J; Shin MC; Liang Q; He H; Yang VC J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]